Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics
Zicheng Hu,1–3 Songhua Fan,1–3 Meiling Liu,1–3 Jiaju Zhong,1–3 Du Cao,1–3 Peng Zheng,1–3 Ying Wang,1–3 Youdong Wei,1–3 Liang Fang,1–3 Peng Xie1–31Department of Neurology, The First Affiliated Hospital...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7ff9cb6b60d446ac8fc62222cbc99889 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:7ff9cb6b60d446ac8fc62222cbc99889 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:7ff9cb6b60d446ac8fc62222cbc998892021-12-02T04:32:20ZObjective diagnosis of post-stroke depression using NMR-based plasma metabonomics1178-2021https://doaj.org/article/7ff9cb6b60d446ac8fc62222cbc998892019-04-01T00:00:00Zhttps://www.dovepress.com/objective-diagnosis-of-post-stroke-depression-using-nmr-based-plasma-m-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Zicheng Hu,1–3 Songhua Fan,1–3 Meiling Liu,1–3 Jiaju Zhong,1–3 Du Cao,1–3 Peng Zheng,1–3 Ying Wang,1–3 Youdong Wei,1–3 Liang Fang,1–3 Peng Xie1–31Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Institute of Neuroscience and the Collaborative Innovation Center for Brain Science, Chongqing Medical University, Chongqing, People’s Republic of China; 3Chongqing Key Laboratory of Neurobiology, Chongqing, People’s Republic of ChinaBackground: Post-stroke depression (PSD) is a frequent and serious complication of stroke. However, the underlying molecular basis of PSD remains largely unknown, and no empirical laboratory tests were available to diagnose this disorder.Materials and methods: A proton nuclear magnetic resonance (1H NMR)-based metabonomic approach was employed to profile plasma samples from 32 PSD, 35 stroke patients and 35 healthy comparison subjects (the training set) in order to identify metabolite biomarkers for PSD. Then, 10 PSD, 11 stroke patients and 11 healthy comparison subjects (test set) were used to validate the diagnostic performance of these biomarkers.Results: The multivariate statistical analysis demonstrated that PSD group was significantly distinguishable from non-PSD groups (non-depression stroke patients and healthy comparison group). Five plasma metabolites (phenylalanine, tyrosine, 1-methylhistidine, 3-methylhistidine and LDL CH3-(CH2)n-) were identified responsible for distinguishing PSD from non-PSD subjects. These metabolites were mainly involved in neurotransmitter metabolism and oxidative stress. The biomarker panel composing of these metabolites was capable of distinguishing test samples with a sensitivity of 100.0% and a specificity of 95.5%.Conclusion: Our findings suggest that plasma disturbances of neurotransmitter levels and oxidative stress were implicated in the onset of PSD; these disturbed metabolites biomarkers facilitate to the development of diagnostic tool for PSD.Keywords: post-stroke depression, stroke, metabonomics, diagnosis, NMRHu ZFan SLiu MZhong JCao DZheng PWang YWei YFang LXie PDove Medical Pressarticlepost-stroke depressionstrokemetabonomicsdiagnosisNMRNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 867-881 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
post-stroke depression stroke metabonomics diagnosis NMR Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
post-stroke depression stroke metabonomics diagnosis NMR Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Hu Z Fan S Liu M Zhong J Cao D Zheng P Wang Y Wei Y Fang L Xie P Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics |
| description |
Zicheng Hu,1–3 Songhua Fan,1–3 Meiling Liu,1–3 Jiaju Zhong,1–3 Du Cao,1–3 Peng Zheng,1–3 Ying Wang,1–3 Youdong Wei,1–3 Liang Fang,1–3 Peng Xie1–31Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Institute of Neuroscience and the Collaborative Innovation Center for Brain Science, Chongqing Medical University, Chongqing, People’s Republic of China; 3Chongqing Key Laboratory of Neurobiology, Chongqing, People’s Republic of ChinaBackground: Post-stroke depression (PSD) is a frequent and serious complication of stroke. However, the underlying molecular basis of PSD remains largely unknown, and no empirical laboratory tests were available to diagnose this disorder.Materials and methods: A proton nuclear magnetic resonance (1H NMR)-based metabonomic approach was employed to profile plasma samples from 32 PSD, 35 stroke patients and 35 healthy comparison subjects (the training set) in order to identify metabolite biomarkers for PSD. Then, 10 PSD, 11 stroke patients and 11 healthy comparison subjects (test set) were used to validate the diagnostic performance of these biomarkers.Results: The multivariate statistical analysis demonstrated that PSD group was significantly distinguishable from non-PSD groups (non-depression stroke patients and healthy comparison group). Five plasma metabolites (phenylalanine, tyrosine, 1-methylhistidine, 3-methylhistidine and LDL CH3-(CH2)n-) were identified responsible for distinguishing PSD from non-PSD subjects. These metabolites were mainly involved in neurotransmitter metabolism and oxidative stress. The biomarker panel composing of these metabolites was capable of distinguishing test samples with a sensitivity of 100.0% and a specificity of 95.5%.Conclusion: Our findings suggest that plasma disturbances of neurotransmitter levels and oxidative stress were implicated in the onset of PSD; these disturbed metabolites biomarkers facilitate to the development of diagnostic tool for PSD.Keywords: post-stroke depression, stroke, metabonomics, diagnosis, NMR |
| format |
article |
| author |
Hu Z Fan S Liu M Zhong J Cao D Zheng P Wang Y Wei Y Fang L Xie P |
| author_facet |
Hu Z Fan S Liu M Zhong J Cao D Zheng P Wang Y Wei Y Fang L Xie P |
| author_sort |
Hu Z |
| title |
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics |
| title_short |
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics |
| title_full |
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics |
| title_fullStr |
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics |
| title_full_unstemmed |
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics |
| title_sort |
objective diagnosis of post-stroke depression using nmr-based plasma metabonomics |
| publisher |
Dove Medical Press |
| publishDate |
2019 |
| url |
https://doaj.org/article/7ff9cb6b60d446ac8fc62222cbc99889 |
| work_keys_str_mv |
AT huz objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT fans objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT lium objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT zhongj objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT caod objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT zhengp objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT wangy objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT weiy objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT fangl objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics AT xiep objectivediagnosisofpoststrokedepressionusingnmrbasedplasmametabonomics |
| _version_ |
1718401197097877504 |